Mucinous cystic naopIasms (MCNs) of the p c r e a s are uncommon tumors. The classifntion and biologic potential of these neoplasms n m a h the subject of controversy. 
Tt is no wonder that the prognostic implications of using this genera1 term for a specific tumor has confused the clinician. confounded the radiologist, and baffled the pathologist.
We Meve that the term MCN should be strictly applied to an uncommon, specific type of tumor, as originally detailed by authors from our institution?' rather than being a vague, confusing, and all-encompassing term. These tumors are g e n d y W e v e d to occur much more frequently in women, in the tail of the panmas, ap@g as an encapsulated unilocular or multilocular cystic, encapsulated mass, o h n diagnosed by radiographic studies, lined by a coIumnar mucin-producing cell, and overlying an ovarian-type stroma with occasional areas of dense cohgenization and surrounding pancreatic atrophy. However, in recent years, there have been several attempts to fuaher subclassify these neoplasms htu dxstinctive clinical, radioIogic, and histopathologic entities2.49,1320.24~2tT30#3(MJJ6464M, 7" similar to the mucinous cystic tumors of the ovary or bdiary system, in which the accepted histoIogic criteria have prognostic and mament i r n p l i c a t i~n s . '~~~' *~~~~~ This type of classification, when applied to the panme atic mucin-producing tumors, is confusing and frustrating. Therefore, a m e analysis of the literature is virtually impossible. as many authors address only a specific characteristic of what they believe is a mucinous cystic neoplasm, Iaclring complete clinical, radiographic, histologic, immunophenotypic, treatment, or follow-up information. Although such studies serve as a valuable adjunct to the understanding of mucinous cystic neoplasms as a group, a more comprehensive approach using all of these parameters applied to a large group of t h e neoplasms was conspicuously absent h m the literature. Therefore, we underrook a study of 130 MCNs, to ow knowledge the largest single series of its kind (MED-LINE 19661998) . in order to catalogue the various characteristics in a single comp&ensive study. It is the intention of this study to determine whether a classification system can differentiate these neoplasms into adenornas, borderline tumors, and malignant tumors in a reproducible fashion by use of cfical symptoms, radiographic images, histomorpholog y, histochemical stains, immunohistochemid studies, cell cycle analysis, or Kras oncogene determination. Fwrthermm. we wish to determine whether this separation yields prognostic or treatment outcomes that are statistically or clinically si&cant.
MATERIALS AND METHODS
One hundred forty-eight cases of MCN of the pancreas were identified in the files of the l3mhrine Tumor Registry at the Armed Forces Institute of Pathology 
Diagnostic investigations
Roentgenographic procedures were performed in the majority of patients, with computer tomography, scanning magnetic resonance imagmg, and ultrasound W i g the most frequently used. Cross-sectional images identified a rounded, well-encapsulated, multicystic, retrogastric mass usually involving the tail or body and tail of the pancreas. Septations could be seen dividing the mucoid to hemorrhagic fluid contents of the cysts into separate cavities (Fig. 1 ). Calcrtications were noted around the piphey within the capsule. Erosion of the organ margins or obliteration of the fat planes suggested a MCNA.
Treatment and Follow-up
Complete surgical excision was the treatment of choice. Most patients were treated by distal, pancreate= tomy and splenectomy (n = 86). an additional 31 patients were w e d by distal pancreatectomy done, and the remaining 13 patients by a partial pancreatectomy (n = 9) or a Whipple procedure (a. = 4). One patient received postoperative chemotherapy.
Eighteen patients were initially treated with a drainage procedure into the gastsohtestinal a t (stomach or jejunum) (n = 16) or to the skin (n = 2), anywhere from I to 34 years before the d e f~t i v e surgical resection. The initial histologrc appearance was interpreted as a pancreatic pseudocyst (n = 12) or as a m~inous cystademma (n = 6). In one case, the rupture of a cyst during surgery was followed by subsequent recurrence of the tumor. The initial biopsy specimens (many of which were avarlable for review) contained foci of tall, columnar, mucinsecreting cells without atypia. These patients continued to have symptoms related to the tumor (given the time intervals, we cannot distinguish between growth of residual tumor or tumor recurrence) and ultimately were heated by surgical excision and complete removal of the cyst, including distal paacreatectomy and splenectomy. One of these patients received chemotherapy and subsequently died of metastatic tumor within 1 year. In 13 of the 18 recurrent cases, cytologic atypia was demonstrated at the h e . of dehitive surgical resection. Twelve of these patients were still alive at last follow-up. The remaining 5 patients with MCMWA were also ahve without evidence of disease at the last follow-up (up to 12 years).
The overall survival for mucinous cystadenocarcinoma of low gracie malignant potential (MCLGMP) was excellent ( 
Pathologic Features

Mucroscopic Features
The majority of the tumors (80%) were located in the tail of the pancreas (Table 5 ). An additional 13.8% (n = 
Microscopic Features
AJI tumors consisted of variable-sized cysts lined by mucin-producing coIumna~ cells. Several sections examined were denuded of epithelium, whether the tumors were MCNWA (n = 60) or MCNA (n = 70). Therefore, many sections were often needed .to demonstrate the epithelial lining, requiring the submission of additional sections, depending on the size of the tumor. Whmas the columnar celIs were often the only cell type identified (usually i n the tumors that had only a single epithelial layer) (Fig. 3A) , gobIet cells with eccentrically placed compressed nuclei, cuboidal cells with eosinophilic cytoplasm, and flattened epithelial. cells could also be seen.
The single row of cells sen in the MCNWA would abruptly develop a cellular pseudostratification two to seven layers thick (Fig. 3B) , going on to form truly stratified papillae with variable fibrovascular cores and p a p illary tufts in MCNA. Cribrifonn and glandular arrangements were interspersed between papillary projections (Fig. 3 B and C) . Nevertheless, the more complex architectural anmgements were i&attfid in the majority of tumors classified as MCNA (n = 59). These changes were noted not only within a single tumor but often in the same. microscopic field (Fig. 3B) . Emphasis must be placed on the abrupt transition or juxtaposition of epithelium with and without atypia. Atypical features (as defind in Materials and Methods) included cells with an increased nuclear-to-cytoplasmic ratio (Fig. 3B) , nuclear hypercbromasia, prominent nucleoli, a loss of nuclear polarity, and architectd disorganization in the papillae (Fig. 3D) Table 6 . Invasion of the smma F i g . red granularity was lost, with a fine layer of luminal bludputp1e alcian blue reactivity (at pH 2.5 with PAS) (Fig. 58) . However, there was a great deal of variability between and within cases, the differences witlhin a given case often being quite striking, Overall, the much character of the epithelial tumor cells was neu;tral to sialated, rather than sulphated mucins of normal, uninvolved ducts.
Imwhistochemical Reactions
ceUs (Fig. 3F) (Fig. 4) . The surrounding pancreas frequently demonstrated atrophic mini, duets, and Glet of Zangerhans, but true panmatitis was conspicuous by its absence,
Histochemical Findings
The tall columnar epithelial cells demonstrated PASpositive, diastase-resistant much (Fig. 5A) , a pale blue reaction with alcian blue (pH 2.5), and light red to blue/ purple granules with PAS and dcian blue. In areas where (Table 7) . The stronger the reactivity with p53, the higher the likelihood for a worse prognosis @ = 0.041) (Fig. 6B) (Table 8 ).
K-rm-2 Oncogene Determination
Not a single case of the tumors tested (25 MCNWA and 27 MCNA) demonstrated a K-ras-2 oncogene mutatio11. Therefore, alI were wild type in the K-ras-2 oncogene. Unfortunately, the olrs cystic neoplasm has k n diluted to include tumors that do not meet the definitions established ear-~4,521,32.43P4,61,7S95,96 Or tho% of the world ~~~l h 0rganization. 5~ In general, the group of tumors encompassed by the term MCN are uncommon tumors, composing about 5% of our consultative cases of primary pancreatic tumors, falling at a point midway between the incidence reported in the literature (1-1 3%).'1+2U,4H5,95 MucinOUs cystic nwpIasms occur predominantly in middle-aged women. Although d l the patients in our study were women, we hasten to add that we do not believe this turnor is exclusive to women. However, the overwhelming majority of 8.10,11,15~,21,2k26,31-33.36~1~~S,57~61,73,79 The two categories of MCNs we tried to create cially had an almost identical average size (10.6 cm) (Table 5 ). Other authors have suggested a difference in size, but their tumor categories are not well defmed.s.ls.79.87.m661m Furthermore, the larger the -or size ( h p e c t i v e of which type), the more lrkely the patient is to have a wwse prognosis, when >I5 cm is used as the cutoff point (p = 0.04) ( Table 8 ). This fmding lends additional. support to our theory that all of the tumors are low-grade malignancies from the start. The two groups also demonstrated a similar anatomic location (tail or body and tail of the pancreas). The only exception were the three patients with jaundice, whose tumors occurred in the head and were all MCNA. Given the overwhehhg a~m b e r of tumors that occur in the tail, a great &aI of circumspection must be applied to those in the head of the pancreas. Thorough Aa identified in our study, there were on avmge more blocks embedded when the cases ultimately demonskated areas of atypia (Table 5) . Of interest-and arguably inadequately sampled-was one patient's tumor from which we did not have an adequate number of sections (only 4 sections in a 13cm tumor) in the MC:
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NWA category, who died of the disease. In addition, there was no statistically sign5cant difference in outcome according to cellular atypia @ = 0.294), architectural complexity @ = 0.36). or tumor invasion @ = 0.201).
As the epithelium becomes more atypical., the character of the much production changes from sulphated to n e u d or sialated mucin. with an increase in the number of goblet cells. (Table 8) .
None of our tumors demonstrated a mutation in the K-ras oncogene. This is in sharp c o n a t to other tumors of the pancreas, especially those of ductal origin. which demonstrate a hrgh mutation rate in K-ras-2 codon. Other author^^^^'*^^*^^ have demonstrated mutations in Kras in mucin-producing tumors of the pancreas, while also demonstrating variable g53 overexpression (tumor suppressor gene product), when immunohistochemical techniques are applied (usually considered to suggest mutated p53). However, we demonstrated p53 overexpression in 41% of our cases, both with and without atypia. As the overall percentage of positive cells for p53 overexpression increased (in association with greater atypia WCNWA = 24% vs. MCNA = 51%]), there was a statistically significant association with a worse patient outcome @ = 0.041) ( Table 8 ). This finding may suggest that p53 mutations may be necessary for the development of carcinoma, with or without K-ras mutation. 66 Nevertheless, K-ras mutations have been iden tified in benign-appearing papillary-mucinous tumors, suggesting that the mutation may be an early event in tum~rigenesis.~~ At the very least, it appears that abnormalities in p53 are unrelated to K-ras mutations. Furthermore, because of the distinct differences between our casa and those of the literature, it is suggested that multiple genetic alterations are responsible for tumorigenesis, expressing phenotypic heter~geneity.~~.'"~~~~ The lack of oncogene mutation limits the application of Kras-2 oncogene analysis in any attempt to separate MCNs into distinct categories (benign, borderline, or malig- 
